This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sedman, S A Articles by Schiller, J T Search for Related Content PubMed PubMed Citation Articles by Sedman, S A Articles by Schiller, J T

 Previous Article  |  Next Article 

J Virol. 1992 July; 66(7): 4201-4208

Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.

Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland 20892.

ABSTRACT

Human papillomavirus type 16 (HPV16) E6 and E7 are selectively retained and expressed in HPV16-associated human genital tumors. E6 is active in several cell culture assays, including transformation of NIH 3T3 cells, trans activation of the adenovirus E2 promoter, and cooperation with E7 to immortalize normal human keratinocytes. Biochemically, the HPV16 E6 protein has been shown to bind to tumor suppressor protein p53 in vitro and induce its degradation in a rabbit reticulocyte lysate. To examine the relationship between the various biological activities of E6 and inactivation of p53, we tested the abilities of dominant negative mutants of p53 to substitute functionally for E6 in the three cell culture assays. While wild-type p53 inhibited keratinocyte proliferation, both mouse and human mutant p53s, in conjunction with E7, increased proliferation of the keratinocytes, resulting in generation of immortalized lines. However, in contrast to E6, mutant p53 was unable to induce transformation or trans activate the adenovirus E2 promoter in NIH 3T3 cells. These results suggest that inactivation of wild-type p53 is necessary for HPV-induced immortalization of human keratinocytes and that different or additional activities are required for E6-dependent transformation and trans activation of NIH 3T3 cells.

This article has been cited by other articles:

• Liu, X., Disbrow, G. L., Yuan, H., Tomaic, V., Schlegel, R. (2007). Myc and Human Papillomavirus Type 16 E7 Genes Cooperate To Immortalize Human Keratinocytes. J. Virol. 81: 12689-12695 [Abstract] [Full Text]  
• Raymond, K., Kreft, M., Janssen, H., Calafat, J., Sonnenberg, A. (2005). Keratinocytes display normal proliferation, survival and differentiation in conditional {beta}4-integrin knockout mice. J. Cell Sci. 118: 1045-1060 [Abstract] [Full Text]  
• McMurray, H. R., McCance, D. J. (2004). Degradation of p53, Not Telomerase Activation, by E6 Is Required for Bypass of Crisis and Immortalization by Human Papillomavirus Type 16 E6/E7. J. Virol. 78: 5698-5706 [Abstract] [Full Text]  
• Shamanin, V. A., Androphy, E. J. (2004). Immortalization of Human Mammary Epithelial Cells Is Associated with Inactivation of the p14ARF-p53 Pathway. Mol. Cell. Biol. 24: 2144-2152 [Abstract] [Full Text]  
• Fan, X., Liu, Y., Chen, J. J. (2003). Activation of c-Myc Contributes to Bovine Papillomavirus Type 1 E7-induced Cell Proliferation. J. Biol. Chem. 278: 43163-43168 [Abstract] [Full Text]  
• Piboonniyom, S.-o., Duensing, S., Swilling, N. W., Hasskarl, J., Hinds, P. W., Munger, K. (2003). Abrogation of the Retinoblastoma Tumor Suppressor Checkpoint During Keratinocyte Immortalization Is Not Sufficient for Induction of Centrosome-mediated Genomic Instability. Cancer Res. 63: 476-483 [Abstract] [Full Text]  
• Simbulan-Rosenthal, C. M., Velena, A., Veldman, T., Schlegel, R., Rosenthal, D. S. (2002). HPV-16 E6/7 Immortalization Sensitizes Human Keratinocytes to Ultraviolet B by Altering the Pathway from Caspase-8 to Caspase-9-dependent Apoptosis. J. Biol. Chem. 277: 24709-24716 [Abstract] [Full Text]  
• Degenhardt, Y. Y., Silverstein, S. J. (2001). Gps2, a Protein Partner for Human Papillomavirus E6 Proteins. J. Virol. 75: 151-160 [Abstract] [Full Text]  
• Goodwin, E. C., Yang, E., Lee, C.-J., Lee, H.-W., DiMaio, D., Hwang, E.-S. (2000). Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. USA 97: 10978-10983 [Abstract] [Full Text]  
• Alarcon, R., Koumenis, C., Geyer, R. K., Maki, C. G., Giaccia, A. J. (1999). Hypoxia Induces p53 Accumulation through MDM2 Down-Regulation and Inhibition of E6-mediated Degradation. Cancer Res. 59: 6046-6051 [Abstract] [Full Text]  
• Song, S., Gulliver, G. A., Lambert, P. F. (1998). Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. Proc. Natl. Acad. Sci. USA 95: 2290-2295 [Abstract] [Full Text]  
• Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T., Ishibashi, M. (1997). Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94: 11612-11616 [Abstract] [Full Text]  
• Chen, J., Reid, C., Band, V, Androphy, E. (1995). Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269: 529-531 [Abstract]  
• Pan, H, Griep, A E (1994). Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.. Genes Dev. 8: 1285-1299 [Abstract]  
• Moles, J., Schiller, J., Tesniere, A, Leigh, I., Guilhou, J., Basset-Seguin, N (1994). Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J. Cell Sci. 107: 435-441 [Abstract]